A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep oncology expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial
ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada
A shared commitment to patients and each other. This is ARIAD.